Agios Pharmaceuticals, Inc. (AGIO)
26.89
-0.57
(-2.08%)
USD |
NASDAQ |
Dec 12, 13:16
Agios Pharmaceuticals Free Cash Flow: -414.09M for Sept. 30, 2025
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Pfizer Inc. | 10.38B |
| Fulcrum Therapeutics, Inc. | -60.41M |
| Moderna, Inc. | -2.663B |
| EyePoint Plc | -213.59M |
| Vanda Pharmaceuticals, Inc. | -82.95M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -88.15M |
| Cash from Investing (Quarterly) | 95.56M |
| Cash from Financing (Quarterly) | 4.435M |
| Free Cash Flow Per Share (Quarterly) | -1.543 |
| Free Cash Flow to Equity (Quarterly) | -85.46M |
| Free Cash Flow to Firm (Quarterly) | -89.71M |
| Free Cash Flow Yield | -26.70% |